| 0 |
Anthelmintic [EPC] |
3 |
0.0010 |
| 1 |
Dihydrofolate Reductase Inhibitor Antimalarial [EPC] |
1 |
0.0008 |
| 2 |
Estrogen Receptor Antagonist [EPC] |
7 |
0.0002 |
| 3 |
Antimetabolite Immunosuppressant [EPC] |
3 |
0.0001 |
| 4 |
Aromatase Inhibitor [EPC] |
9 |
0.0001 |
| 5 |
CD52-directed Cytolytic Antibody [EPC] |
1 |
0.0001 |
| 6 |
Protease Inhibitor [EPC] |
2 |
0.0000 |
| 7 |
Cytochrome P450 3A Inhibitor [EPC] |
2 |
0.0000 |
| 8 |
Pyrimidine Synthesis Inhibitor [EPC] |
1 |
0.0000 |
| 9 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 10 |
Antirheumatic Agent [EPC] |
2 |
0.0000 |
| 11 |
Interleukin-6 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 12 |
Selective T Cell Costimulation Modulator [EPC] |
2 |
0.0000 |
| 13 |
Anti-IgE [EPC] |
1 |
0.0000 |
| 14 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
1 |
0.0000 |
| 15 |
CD20-directed Cytolytic Antibody [EPC] |
3 |
0.0000 |
| 16 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 17 |
Proteasome Inhibitor [EPC] |
1 |
0.0000 |
| 18 |
P2Y12 Platelet Inhibitor [EPC] |
1 |
0.0000 |
| 19 |
Tumor Necrosis Factor Blocker [EPC] |
8 |
0.0000 |
| 20 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
1 |
0.0000 |
| 21 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 22 |
beta-Adrenergic Blocker [EPC] |
2 |
0.0000 |
| 23 |
Janus Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 24 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
3 |
0.0000 |
| 25 |
Folate Analog Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 26 |
Alkylating Drug [EPC] |
1 |
0.0000 |
| 27 |
Corticosteroid [EPC] |
5 |
0.0000 |
| 28 |
Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 29 |
Dihydropyridine Calcium Channel Blocker [EPC] |
1 |
0.0000 |
| 30 |
HMG-CoA Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 31 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |
| 32 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
2 |
0.0000 |